{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:39:13Z","timestamp":1768559953718,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":53,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31270807"],"award-info":[{"award-number":["31270807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Projects in the National Science & Technology Pillar Program in the Thirteenth Five-year Plan Period","award":["2018ZX10731101-002-003"],"award-info":[{"award-number":["2018ZX10731101-002-003"]}]},{"DOI":"10.13039\/501100013284","name":"JLU | Program for Jilin University Science and Technology Innovative Research Team","doi-asserted-by":"publisher","award":["2017TD-05"],"award-info":[{"award-number":["2017TD-05"]}],"id":[{"id":"10.13039\/501100013284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1074\/jbc.ra120.013404","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:45:30Z","timestamp":1597884330000},"page":"14592-14605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif\/CBF\u03b2 interaction"],"prefix":"10.1016","volume":"295","author":[{"given":"Sizhu","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0308-3329","authenticated-orcid":false,"given":"Nan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Gai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA120.013404_bib1","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front. Immun."},{"key":"10.1074\/jbc.RA120.013404_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sbi.2015.04.004","article-title":"HIV suppression by host restriction factors and viral immune evasion","volume":"31","author":"Jia","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1074\/jbc.RA120.013404_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.semcdb.2011.10.004","article-title":"Functions and regulation of the APOBEC family of proteins","volume":"23","author":"Smith","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1074\/jbc.RA120.013404_bib5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.8511591","article-title":"Molecular cloning of an apolipoprotein B messenger RNA editing RNA","volume":"260","author":"Teng","year":"1993","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013404_bib6","doi-asserted-by":"crossref","first-page":"34083","DOI":"10.1074\/jbc.C400235200","article-title":"APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein","volume":"279","author":"Alce","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib7","doi-asserted-by":"crossref","first-page":"e1004609","DOI":"10.1371\/journal.ppat.1004609","article-title":"Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1","volume":"11","author":"Luis","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.RA120.013404_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-4690-4-48","article-title":"Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions","volume":"4","author":"Khan","year":"2007","journal-title":"Retrovirology."},{"key":"10.1074\/jbc.RA120.013404_bib9","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.01038-06","article-title":"Inhibition of tRNA3(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication","volume":"80","author":"Guo","year":"2006","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib10","doi-asserted-by":"crossref","first-page":"32065","DOI":"10.1074\/jbc.M703423200","article-title":"APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription","volume":"282","author":"Xiao-Yu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Bastien","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell."},{"key":"10.1074\/jbc.RA120.013404_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein","volume":"300","author":"Denise","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013404_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni0703-641","article-title":"DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses","volume":"4","author":"Harris","year":"2003","journal-title":"Nat. Immun."},{"key":"10.1074\/jbc.RA120.013404_bib15","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1074\/jbc.M707586200","article-title":"Human cytidine deaminase APOBEC3H restricts HIV-1 replication","volume":"283","author":"Dang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/nar\/gkj416","article-title":"APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells","volume":"34","author":"Bogerd","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1074\/jbc.RA120.013404_bib17","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.01123-06","article-title":"Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family","volume":"80","author":"Dang","year":"2006","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cub.2004.06.050","article-title":"APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo","volume":"14","author":"Liddament","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1074\/jbc.RA120.013404_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.3497453","article-title":"The sor gene of HIV-1 is required for efficient virus transmission in vitro","volume":"237","author":"Fisher","year":"1987","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013404_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/328728a0","article-title":"The HIV A (sor) gene product is essential for virus infectivity","volume":"328","author":"Strebel","year":"1987","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol. Cell."},{"key":"10.1074\/jbc.RA120.013404_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.micinf.2004.04.011","article-title":"Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation","volume":"6","author":"Fujita","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1074\/jbc.RA120.013404_bib23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013404_bib24","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines","volume":"18","author":"Yu","year":"2004","journal-title":"Genes Dev."},{"key":"10.1074\/jbc.RA120.013404_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-\u03b2 to degrade APOBEC3G and promote HIV-1 infection","volume":"481","author":"J\u00e4ger","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib26","first-page":"376","article-title":"T-cell differentiation factor CBF-\u03b2 regulates HIV-1 Vif-mediated evasion of host restriction","volume":"481","author":"Wenyan","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib27","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1128\/JVI.03359-13","article-title":"CBF\u03b2 enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G","volume":"88","author":"Miyagi","year":"2014","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.molcel.2012.12.012","article-title":"CBF\u03b2 stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression","volume":"49","author":"Kim","year":"2013","journal-title":"Mol. Cell."},{"key":"10.1074\/jbc.RA120.013404_bib29","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JVI.03824-13","article-title":"Core binding factor \u03b2 plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase","volume":"88","author":"Fribourgh","year":"2014","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12884","article-title":"Structural basis for hijacking CBF-\u03b2 and CUL5 E3 ligase complex by HIV-1 Vif","volume":"505","author":"Guo","year":"2014","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013404_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2013.11.004","article-title":"Defining HIV-1 Vif residues that interact with CBF\u03b2 by site-directed mutagenesis","volume":"449","author":"Matsui","year":"2014","journal-title":"Virology."},{"key":"10.1074\/jbc.RA120.013404_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4690-11-4","article-title":"HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3","volume":"11","author":"Evans","year":"2014","journal-title":"Retrovirology."},{"key":"10.1074\/jbc.RA120.013404_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12977-017-0346-5","article-title":"Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBF\u03b2 that is critical for Vif function","volume":"14","author":"Desimmie","year":"2017","journal-title":"Retrovirology."},{"key":"10.1074\/jbc.RA120.013404_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molmed.2018.03.004","article-title":"A new class of antiretroviral enabling innate immunity by protecting APOBEC3 from HIV Vif-dependent degradation","volume":"24","author":"Bennett","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1074\/jbc.RA120.013404_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2016.11.001","article-title":"An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation","volume":"136","author":"Bennett","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1074\/jbc.RA120.013404_bib36","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.M109.085308","article-title":"Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G","volume":"285","author":"Cen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib37","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1074\/jbc.M114.626903","article-title":"Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein","volume":"290","author":"Pery","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib38","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2015.03.050","article-title":"Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein","volume":"95","author":"Pan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1074\/jbc.RA120.013404_bib39","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/JVI.06957-11","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC","volume":"86","author":"Zuo","year":"2012","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2015.07.009","article-title":"Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif\u2013APOBEC3G complex","volume":"122","author":"Zhang","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1074\/jbc.RA120.013404_bib41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1743-422X-11-122","article-title":"Small molecules that inhibit Vif-induced degradation of APOBEC3G","volume":"11","author":"Matsui","year":"2014","journal-title":"Virol. J."},{"key":"10.1074\/jbc.RA120.013404_bib42","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.bmcl.2017.07.026","article-title":"Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors","volume":"27","author":"Pu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1074\/jbc.RA120.013404_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1098\/rstb.2008.0185","article-title":"APOBEC proteins and intrinsic resistance to HIV-1 infection","volume":"364","author":"Malim","year":"2009","journal-title":"Philos Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1074\/jbc.RA120.013404_bib44","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1128\/jvi.67.8.4945-4955.1993","article-title":"Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells","volume":"67","author":"Schwedler","year":"1993","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib45","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1128\/jvi.66.11.6489-6495.1992","article-title":"Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes","volume":"66","author":"Gabuzda","year":"1992","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/JVI.77.2.1131-1140.2003","article-title":"Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection","volume":"77","author":"Kao","year":"2003","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jgv.0.000027","article-title":"Vif determines the requirement for CBF-\u03b2 in APOBEC3 degradation","volume":"96","author":"Yoshikawa","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib48","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1128\/JVI.01924-14","article-title":"Core-binding factor subunit \u03b2 is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation","volume":"88","author":"Youwei","year":"2014","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib49","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2015.04.038","article-title":"Lineage-specific viral hijacking of non-canonical E3 ubiquitin ligase cofactors in the evolution of Vif anti-APOBEC3 activity","volume":"11","author":"Kane","year":"2015","journal-title":"Cell Rep."},{"key":"10.1074\/jbc.RA120.013404_bib50","doi-asserted-by":"crossref","first-page":"e18296","DOI":"10.7554\/eLife.18296","article-title":"Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants","volume":"5","author":"Greenwood","year":"2016","journal-title":"eLife."},{"key":"10.1074\/jbc.RA120.013404_bib51","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1089\/aid.2012.0142","article-title":"HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor \u03b2 on genetically distinct surfaces","volume":"28","author":"Hultquist","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses."},{"key":"10.1074\/jbc.RA120.013404_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tibs.2014.07.001","article-title":"Structural insights for HIV-1 therapeutic strategies targeting Vif","volume":"39","author":"Salter","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1074\/jbc.RA120.013404_bib53","doi-asserted-by":"crossref","first-page":"e53036","DOI":"10.7554\/eLife.53036","article-title":"Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest","volume":"9","author":"Marelli","year":"2020","journal-title":"eLife."},{"key":"10.1074\/jbc.RA120.013404_bib54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.celrep.2019.09.057","article-title":"HIV-1 Vif triggers cell cycle arrest by degrading cellular PPP2R5 phospho-regulators","volume":"29","author":"Salamango","year":"2019","journal-title":"Cell Rep."},{"key":"10.1074\/jbc.RA120.013404_bib55","doi-asserted-by":"crossref","first-page":"e01708","DOI":"10.1128\/JVI.01708-19","article-title":"Inhibition of Vif-mediated degradation of APOBEC3G through competitive binding of core-binding factor \u03b2","volume":"94","author":"Miyagi","year":"2020","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib56","doi-asserted-by":"crossref","first-page":"e1500296","DOI":"10.1126\/sciadv.1500296","article-title":"Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-\u03b2\/RUNX axis","volume":"1","author":"Anderson","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1074\/jbc.RA120.013404_bib57","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15 - ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1074\/jbc.RA120.013404_bib58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/jvi.71.2.1443-1452.1997","article-title":"Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes","volume":"71","author":"Lee","year":"1997","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib59","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/JVI.78.4.2072-2081.2004","article-title":"Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G","volume":"78","author":"Bindong","year":"2004","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA120.013404_bib60","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bpj.2008.09.054","article-title":"Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers","volume":"96","author":"Harding","year":"2009","journal-title":"Biophys. J."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817493380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817493380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA120.013404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T16:13:55Z","timestamp":1640967235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817493380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0021925817493380"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra120.013404","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif\/CBF\u03b2 interaction","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA120.013404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}